QHSLab, Inc.
USAQ
$0.2398
$0.024811.54%
| Weiss Ratings | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.29 | |||
| Price History | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -17.05% | |||
| 30-Day Total Return | 14.19% | |||
| 60-Day Total Return | 26.21% | |||
| 90-Day Total Return | 59.87% | |||
| Year to Date Total Return | -10.92% | |||
| 1-Year Total Return | 336.00% | |||
| 2-Year Total Return | 99.83% | |||
| 3-Year Total Return | -56.40% | |||
| 5-Year Total Return | 139.80% | |||
| 52-Week High % Change | -44.94% | |||
| 52-Week Low % Change | 499.50% | |||
| Price | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.44 | |||
| 52-Week Low Price | $0.04 | |||
| 52-Week Low Price (Date) | Mar 18, 2024 | |||
| 52-Week High Price (Date) | Dec 20, 2024 | |||
| Valuation | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.71M | |||
| Enterprise Value | 4.34M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -85.78% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.44 | |||
| Price/Book (Q) | -7.49 | |||
| Enterprise Value/Revenue (TTM) | 2.38 | |||
| Price | $0.24 | |||
| Enterprise Value/EBITDA (TTM) | 27.76 | |||
| Enterprise Value/EBIT | 51.48 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 18.54M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 929 379 6503 | |||
| Address | 901 Northpoint Parkway West Palm Beach, FL 33407 | |||
| Website | www.usaqcorp.com | |||
| Country | United States | |||
| Year Founded | 1983 | |||
| Profitability | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 4.62% | |||
| Profit Margin | -3.19% | |||
| Management Effectiveness | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.01% | |||
| Return on Equity | -- | |||
| Income Statement | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.82M | |||
| Total Revenue (TTM) | 1.82M | |||
| Revenue Per Share | $0.10 | |||
| Gross Profit (TTM) | 1.14M | |||
| EBITDA (TTM) | 156.30K | |||
| EBIT (TTM) | 84.30K | |||
| Net Income (TTM) | -58.20K | |||
| Net Income Avl. to Common (TTM) | -58.20K | |||
| Total Revenue Growth (Q YOY) | 61.80% | |||
| Earnings Growth (Q YOY) | 160.44% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 127.00% | |||
| Balance Sheet | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 95.90K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 349.30K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -335.30K | |||
| Current Ratio (Q) | 0.167 | |||
| Book Value Per Share (Q) | -$0.03 | |||
| Total Assets (Q) | 1.76M | |||
| Total Current Liabilities (Q) | 2.09M | |||
| Total Debt (Q) | 1.73M | |||
| Total Liabilities (Q) | 2.10M | |||
| Total Common Equity (Q) | -335.60K | |||
| Cash Flow | USAQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 93.50K | |||
| Net Change in Cash (TTM) | 45.60K | |||
| Levered Free Cash Flow (TTM) | -25.90K | |||
| Cash from Operations (TTM) | -47.80K | |||
